Abiopharma

New Form SC TO-T - DURECT CORP Filed: 2025-08-12 AccNo: 0001193125-25-178491 Size: 1 MB

New Form 10-Q - Monopar Therapeutics Filed: 2025-08-12 AccNo: 0001437749-25-026042 Size: 5 MB

Ecolab Inc. - Ecolab to Acquire Ovivo’s Electronics Ultra-Pure Water Business

New Form 8-K - Grace Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0001140361-25-030400 Size: 322 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - MIRA PHARMACEUTICALS, INC. Filed: 2025-08-12 AccNo: 0001641172-25-023110 Size: 212 KB Item 8.01: Other Events

Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Ginkgo Automation Appoints Brian OSullivan as Head of Commercial to Accelerate External Growth

Financial Statements and Related Announcement: Half Yearly Results

ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment

IM Cannabis Reports Second Quarter 2025 Financial Results

Monopar Therapeutics ReportsSecond Quarter 2025 Financial Results and Recent Developments

Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update

Elicio Therapeutics Announces Publication of ELI-002 Updated AMPLIFY-201 Phase 1 Follow-up Data in Nature Medicine for Minimal Residual Disease (“MRD”) Positive, Adjuvant-Stage Patients

electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga

180 Life Sciences (ETHZilla) Holds 82,186 ETH